Andrew Serafin is CHIEF STRATEGY OFFICER of Harmony Biosciences Holdings, Inc.. Currently has a direct ownership of 1,635 shares of HRMY, which is worth approximately $63,274. The most recent transaction as insider was on Jan 24, 2025, when has been sold 865 shares (Common Stock) at a price of $38.01 per share, resulting in proceeds of $32,878. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.64K
Infinity% 3M change
Infinity% 12M change
Total Value Held $63,274

Andrew Serafin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2025
SELL
Payment of exercise price or tax liability
$32,878 $38.01 p/Share
865 Reduced 34.6%
1,635 Common Stock
Jan 24 2025
BUY
Exercise of conversion of derivative security
-
2,500 Added 50.0%
2,500 Common Stock
Dec 02 2022
SELL
Open market or private sale
$2,295,580 $60.41 p/Share
38,000 Reduced 100.0%
0 Common Stock
Dec 02 2022
BUY
Exercise of conversion of derivative security
$312,360 $8.22 p/Share
38,000 Added 50.0%
38,000 Common Stock
AS

Andrew Serafin

CHIEF STRATEGY OFFICER
Plymouth Meeting, PA

Track Institutional and Insider Activities on HRMY

Follow Harmony Biosciences Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRMY shares.

Notify only if

Insider Trading

Get notified when an Harmony Biosciences Holdings, Inc. insider buys or sells HRMY shares.

Notify only if

News

Receive news related to Harmony Biosciences Holdings, Inc.

Track Activities on HRMY